$599
Awiqli US Launch; AZ Ph3 Eleco CKD Study; BI Ph3 Survo T2DM Study; Abbott + Google Glucose Partnership
A series of cardiometabolic-related news items has been observed from Novo Nordisk, AstraZeneca, Boehringer Ingelheim, and Abbott/Google. Below, FENIX provides highlights and insights for the respective news items.
This content is for Read Less members only.
Already a member? Log in here
OR